A Digital Health App to Prevent Falls and Improve Well-being in People Living With Dementia
NCT ID: NCT06149702
Last Updated: 2025-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
60 participants
INTERVENTIONAL
2024-06-30
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Keep-On-Keep-Up (KOKU)
NCT06687135
Keep Exercising & Stay Steady: Development and Feasibility of a Digital Health Intervention to Encourage Exercise Maintenance After Fall Prevention Exercise Programmes End.
NCT06447948
Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk
NCT05022589
Virtual Reality Activity-based Training for Preventing Falls for Older Adults With Mild Cognitive Impairment
NCT05971420
The SafeTrip Study - Step Training to Reduce Falls in Older Adults
NCT04602858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention: Keep-on-Keep-Up-LITE (KOKU-LITE) programme and dementia and falls prevention leaflet
Intervention arm: Keep-on-Keep-Up-LITE (KOKU-LITE) programme and dementia and falls prevention leaflet.
Participants will attend a KOKU-LITE training session lasting for 60 minutes. A carer may also accompany if the participant feels that their support would be beneficial. An iPad will be provided to participants for the duration of the project and the app instruction booklet will also be provided for reference purposes. For participants who do not wish to attend the group training, ad hoc one-to-one training will be offered. \* Participants will be advised to use KOKU-LITE for 30 minutes, 3 times per week, for 6 weeks and also read the dementia and falls prevention leaflet
Combined intervention: Keep-on-Keep-Up-LITE (KOKU-LITE) programme and dementia and falls prevention leaflet
KOKU-LITE programme will be used by the participants for 6 weeks and outcome assessments will be performed at baseline and 6 weeks of use. Participants will also use dementia and falls prevention leaflet for 6 weeks.
Control arm (Dementia and Falls prevention leaflet)
If participants are allocated to the intervention group, they will use KOKU-LITE for 30 minutes 3 times a week for 6 weeks along with the dementia and falls prevention leaflet. If participants are allocated to the control group, they will receive Dementia and Falls prevention leaflet (https://www.dementiauk.org/wp-content/uploads/dementia-uk-falls.pdf)l (and not use KOKU-LITE).
Combined intervention: Keep-on-Keep-Up-LITE (KOKU-LITE) programme and dementia and falls prevention leaflet
KOKU-LITE programme will be used by the participants for 6 weeks and outcome assessments will be performed at baseline and 6 weeks of use. Participants will also use dementia and falls prevention leaflet for 6 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined intervention: Keep-on-Keep-Up-LITE (KOKU-LITE) programme and dementia and falls prevention leaflet
KOKU-LITE programme will be used by the participants for 6 weeks and outcome assessments will be performed at baseline and 6 weeks of use. Participants will also use dementia and falls prevention leaflet for 6 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PLwD and carers of PLwD aged ≥55 yrs
* willing and able to give informed consent (assessed by the trained researchers and/or health and social care professionals (HSCPs)).
* who lack capacity to consent themselves but can be supported by a carer or an advocate.
* Carers of PLwD who lack capacity to consent themselves.
* able to speak English.
* able to see the tablet/iPad-based app and read instructions with or without glasses.
* able to use tablet/iPad safely, as assessed by the trained research staff and/or HSCPs.
* able to move indoors without help, and with or without a walking aid.
Professionals
• HSCPs caring for PLwD
Exclusion Criteria
* Participants with:
* Acute/chronic or uncontrolled medical condition (e.g. severe congestive cardiac failure, uncontrolled hypertension, acute systemic illness, neurological problems, poorly controlled diabetes).
* recent fracture or surgery (within 6 months)
* orthopaedic surgery (such as hip/knee surgery) in the past six months or on a waiting list to have the surgery.
* heart problems such as myocardial infarction or stroke in the past six months
* conditions requiring a specialist/exercise programme (e.g., uncontrolled epilepsy, or uses a wheelchair to mobilise indoors).
* severe hearing/visual impairment.
* any other medical condition likely to compromise the ability to use/access the app.
* Participants currently in hospital or care home,
* Participants who have limited understanding or ability to speak English, and .
* Persons with Dementia who do not have a carer who can provide assent.
55 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jaheeda Gangannagaripalli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaheeda Gangannagaripalli
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaheeda Begum Gangannagaripalli, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Manchester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Manchester
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gangannagaripalli J, Vardy E, Stanmore E. A digital programme to prevent falls and improve well-being in people living with dementia in the community: the KOKU-LITE feasibility randomised controlled trial protocol. BMJ Open. 2025 Aug 19;15(8):e091222. doi: 10.1136/bmjopen-2024-091222.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version 3.1, 13.05.24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.